[Construction and verification of the dual-promoter plasmid pCN-SSISG as bivalent anti-caries DNA vaccine].
The aim of the study is to construct an anti-caries DNA vaccine with high immunogenicity due to its unique properties of being able to express target antigens both in eukaryotic and prokaryotic host cells and harboring two main virulence genes from caries pathogen Streptoccocus mutans (S. mutans). The gene encoding glucan binding region (GBR) of glucosyltransferase-I (GTF-I) was amplified from the plasmid harboring the gtfB gene from S. mutans by PCR. Then the GBR gene that was upstream linked with tissue-type plasminogen activator signal peptide (tPA-SP) was directly cloned into the plasmid pCN-SSIE containing sSBR gene encoding tPA-SP and saliva binding region (SBR) of antigen protein I/II (AgI/II) from S. mutans. And finally the recombinant plasmid pCN-SSISG was analysed by DNA sequencing and endonuclearase digestion mapping. DNA sequencing and endonuclearase digestion mapping showed that the open reading frame (ORF) and the tPA-SP sequence of the recombinant plasmid pCN-SSISG were identical with the expectant ones. We have successfully constructed the dual-promoter bivalent recombinant plasmid pCN-SSISG.